These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3907557)

  • 21. Resistance of Plasmodium falciparum to pyrimethamine and proguanil in Netherlands New Guinea.
    MEUWISSEN JH
    Am J Trop Med Hyg; 1961 Mar; 10():135-9. PubMed ID: 13769941
    [No Abstract]   [Full Text] [Related]  

  • 22. Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria.
    Peterson DS; Milhous WK; Wellems TE
    Proc Natl Acad Sci U S A; 1990 Apr; 87(8):3018-22. PubMed ID: 2183222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug-resistant malaria--changing patterns mean difficult decisions.
    Spencer HC
    Trans R Soc Trop Med Hyg; 1985; 79(6):748-58. PubMed ID: 3914115
    [No Abstract]   [Full Text] [Related]  

  • 24. Evaluation of sporontocidal compounds using Plasmodium falciparum gametocytes produced in vitro.
    Teklehaimanot A; Nguyen-Dinh P; Collins WE; Barber AM; Campbell CC
    Am J Trop Med Hyg; 1985 May; 34(3):429-34. PubMed ID: 3890574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of an in vitro assay system for drug susceptibility of field isolates of Plasmodium falciparum from southern Thailand.
    Childs GE; Wimonwattrawatee T; Pooyindee N
    Am J Trop Med Hyg; 1988 Jan; 38(1):19-23. PubMed ID: 3277459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro antimalarial activity of tetrahydrofolate dehydrogenase inhibitors.
    Sixsmith DG; Watkins WM; Chulay JD; Spencer HC
    Am J Trop Med Hyg; 1984 Sep; 33(5):772-6. PubMed ID: 6385738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro activity of pyrimethamine, cycloguanil, and other antimalarial drugs against African isolates and clones of Plasmodium falciparum.
    Basco LK; Ramiliarisoa O; Le Bras J
    Am J Trop Med Hyg; 1994 Feb; 50(2):193-9. PubMed ID: 8116812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of resistance to pyrimethamine/sulphadoxine of isolates of Plasmodium falciparum from Eastern Thailand.
    Childs GE; Sabchareon A; Chongsuphajaisiddi T; Wimonwattrawatee T; Ratharatorn B; Webster HK
    Trans R Soc Trop Med Hyg; 1986; 80(1):66-8. PubMed ID: 3523866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Community pyrimethamine-sulfadoxine use and prevalence of resistant Plasmodium falciparum genotypes in Mali: a model for deterring resistance.
    Plowe CV; Djimde A; Wellems TE; Diop S; Kouriba B; Doumbo OK
    Am J Trop Med Hyg; 1996 Nov; 55(5):467-71. PubMed ID: 8940973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mefloquine sulfadoxine pyrimethamine (MSP) combination delays in vitro emergence of mefloquine resistance in multiple drug resistant Plasmodium falciparum.
    Brockelman CR; Thanomsub B; Bhisutthibhand J
    Southeast Asian J Trop Med Public Health; 1989 Sep; 20(3):371-8. PubMed ID: 2699083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Roll back of Plasmodium falciparum antifolate resistance by insecticide-treated nets.
    Zimmerman PA
    Am J Trop Med Hyg; 2003 Sep; 69(3):236-7. PubMed ID: 14628936
    [No Abstract]   [Full Text] [Related]  

  • 32. Susceptibility studies of Malaysian Plasmodium falciparum clones to type II antifolate drugs after 3 years of continuous in vitro culture.
    Ang HH; Cheang HS; Mak JW
    Chemotherapy; 2005 Oct; 51(6):377-80. PubMed ID: 16227695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of Fansidar against Plasmodium falciparum in continuous culture.
    Brockelman CR; Tan-Ariya P
    Am J Trop Med Hyg; 1982 Sep; 31(5):913-8. PubMed ID: 6751112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular epidemiology of malaria in Yaounde, Cameroon. VI. Sequence variations in the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene and in vitro resistance to pyrimethamine and cycloguanil.
    Basco LK; Ringwald P
    Am J Trop Med Hyg; 2000 Feb; 62(2):271-6. PubMed ID: 10813484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The activity of pyrimethamine and sulphadoxine against Plasmodium falciparum determined by the in vitro microtechnique.
    Eastham GM; Rieckmann KH
    Trans R Soc Trop Med Hyg; 1983; 77(1):91-3. PubMed ID: 6344364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Response to treatment in man of multi-drug resistant Plasmodium falciparum from Panama.
    Glew RH; Miller LH; Collins WE; Howard WA; Wyler DJ; Chaves-Carballo E; Neva FA
    Am J Trop Med Hyg; 1974 Jan; 23(1):1-7. PubMed ID: 4204024
    [No Abstract]   [Full Text] [Related]  

  • 37. Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance.
    Foote SJ; Galatis D; Cowman AF
    Proc Natl Acad Sci U S A; 1990 Apr; 87(8):3014-7. PubMed ID: 2183221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A simple field kit for the determination of drug susceptibility in Plasmodium falciparum.
    Nguyen-Dinh P; Magloire R; Chin W
    Am J Trop Med Hyg; 1983 May; 32(3):452-5. PubMed ID: 6344669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro microtechnique for determining the drug susceptibility of cultured parasites of Plasmodium falciparum.
    Yisunsri L; Rieckmann K
    Trans R Soc Trop Med Hyg; 1980; 74(6):809-10. PubMed ID: 7010702
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacodynamic interaction between atovaquone and other antimalarial compounds against Plasmodium falciparum in vitro.
    Lütgendorf C; Rojanawatsirivet C; Wernsdorfer G; Sirichaisinthop J; Kollaritsch H; Wernsdorfer WH
    Wien Klin Wochenschr; 2006; 118(19-20 Suppl 3):70-6. PubMed ID: 17131244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.